Zobrazeno 1 - 5
of 5
pro vyhledávání: '"algeron"'
Autor:
O. O. Znoyko, M. V. Maevskaya, E. A. Klimova, S. L. Maksimov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, R. A. Ivanov, Yu. N. Linkova, T. V. Chernovskaya
Publikováno v:
Журнал инфектологии, Vol 5, Iss 1, Pp 83-90 (2014)
Algeron (cepeginterferon alfa-2b) is a new pegylated form of interferon alfa containing linear polyethylene glycol (molecular weight 20 kDa). Pharmacokinetic profile of Algeron allows once weekly administration. In phase II–III study 150 treatment-
Externí odkaz:
https://doaj.org/article/8309c85f05cb4ce69fe7e97dad55ad44
Autor:
M. V. Mayevskaya, O. O. Znoyko, Ye. A. Klimova, S. L. Maximov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, Yu. N. Linkova
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 24, Iss 2, Pp 53-64 (2014)
Aim of investigation. Comparative study of efficacy and safety of Algeron in dozes of 1,5 and 2,0 mkg/kg and PegIntron in combination to ribavirin within combined mode of treatment of patients with chronic hepatitis C (CHC) with subsequent assessment
Externí odkaz:
https://doaj.org/article/669a8954f13c48a996ee55f26090f58f
Autor:
M. V. Mayevskaya, O. O. Znoyko, E. A. Klimova, S. L. Maximov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, R. A. Ivanov, Yu. N. Linkova, T. V. Chernovskaya
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 23, Iss 1, Pp 30-36 (2013)
Aim of the study. To compare efficacy and safety of Algeron 1.5 and 2.0 μg/kg with PegIntron in combination with ribavirin in the treatment of chronic hepatitis C and to determine therapeutic dose of Algeron.Materials and Methods. 150 adult treatmen
Externí odkaz:
https://doaj.org/article/ba56af4b112c4c51b8bd662454878759
Publikováno v:
Практическая медицина.
Проведено изучение эффективности и безопасности применения препарата «Альгерон» в рамках комбинированной терапии хронического гепат
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2806::8d58dff6f3f4611cf3719da4054b4ef0
http://cyberleninka.ru/article/n/opyt-ispolzovaniya-otechestvennogo-pegilirovannogo-interferona-algeron-v-lechenii-hronicheskogo-gepatita-s
http://cyberleninka.ru/article/n/opyt-ispolzovaniya-otechestvennogo-pegilirovannogo-interferona-algeron-v-lechenii-hronicheskogo-gepatita-s